Metraipolis › archive › dc_945f18248dbf
Development and Validation of a Novel Indicator for Differential Diagnosis of Clinically Significant Prostate Cancer Based on Comprehensive Hematological… — Europe PMC PMID:42351543
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42351543
- DOI
- 10.3390/diagnostics16121884
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T04:14:23.436Z
- SHA-256 of the archived text
e4d975fc611f8d301de5af319ccf0f2241f4328f5b3e6422edd88e3dfa075676- Stable URL of this page
https://metraipolis.com/documento/dc_945f18248dbf
How to cite
Development and Validation of a Novel Indicator for Differential Diagnosis of Clinically Significant Prostate Cancer Based on Comprehensive Hematological… — Europe PMC PMID:42351543 — Europe PMC (en), https://europepmc.org/article/MED/42351543 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_945f18248dbf (Metraipolis archive dc_945f18248dbf, sha256 e4d975fc611f8d301de5af319ccf0f2241f4328f5b3e6422edd88e3dfa075676)
BibTeX
@misc{dc945f18248dbf,
title = {Development and Validation of a Novel Indicator for Differential Diagnosis of Clinically Significant Prostate Cancer Based on Comprehensive Hematological… — Europe PMC PMID:42351543},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42351543},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_945f18248dbf; sha256 e4d975fc611f8d301de5af319ccf0f2241f4328f5b3e6422edd88e3dfa075676},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42351543. Agents can read the archived copy with the MCP tool read_document.